Drawing based on the label description. No photo yet.
“Tablets: 250 mg as a blue oval-shaped film-coated tablet debossed "IVO" on one side and "250" on the other side”
IVO 250 pill
Pill with imprint IVO 250 is blue, oval, 18 mm and has been identified as Ivosidenib 250 mg. It is used for acute myeloid leukemia. It is supplied by Servier Pharmaceutical LLC.
Ivosidenib 250 mg
- Imprint
- IVO 250
- Strength
- 250 mg
- Used for
- Acute myeloid leukemia
- Color
- Blue
- Shape
- Oval
- Size
- 18 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Servier Pharmaceutical LLC
- Drug class
- Isocitrate dehydrogenase 1 inhibitor
- NDC
- 72694-617, 72694-617-60
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Ivosidenib used for?
Ivosidenib is used for acute myeloid leukemia.
- Medicine type
- Isocitrate dehydrogenase 1 inhibitor
Official uses from the US prescribing label
Newly Diagnosed Acute Myeloid Leukemia
TIBSOVO is indicated in combination with azacitidine or as monotherapy for the treatment of newly diagnosed acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
Relapsed or Refractory Acute Myeloid Leukemia
TIBSOVO is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.
Relapsed or Refractory Myelodysplastic Syndromes
TIBSOVO is indicated for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.
Locally Advanced or Metastatic Cholangiocarcinoma
TIBSOVO is indicated for the treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.
From the FDA-approved label on DailyMed (published Dec 22, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows IVO and the other side shows 250.
- It is blue, oval, 18 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Tibsovo.
Ingredients
Active: Ivosidenib
Inactive: Silicon Dioxide, Croscarmellose Sodium, Hypromellose Acetate Succinate 06081224 (3 Mpa.s), Magnesium Stearate, Microcrystalline Cellulose, Sodium Lauryl Sulfate, Fd&c Blue No. 2, Hypromellose, Unspecified, Lactose Monohydrate, Titanium Dioxide, Triacetin
Other pills with imprint IVO 250
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
LAC 200
Lacosamide 200 mg
Blue, oval, 17 mm
Used for focal seizures and tonic-clonic seizures
Schedule V
-
OPC 50
Opicapone 50 mg
Blue, oval, 19 mm
Used for Parkinson's disease
-
OPC 25
Opicapone 25 mg
Blue, oval, 19 mm
Used for Parkinson's disease
-
IF826
Ibuprofen and Famotidine 800 mg / 26.6 mg
Blue, oval, 19 mm
Used for arthritis
-
AC11
Etodolac 500 mg
Blue, oval, 19 mm
Used for pain and rheumatoid arthritis
- RP 300 Maraviroc 300 mg Blue, oval, 19 mm Used for HIV